Andrew Osborne

Andrew Osborne is currently the Head of Biology at Ikarovec Limited. With previous experience as a Lead Investigator at Astellas Pharma and Principal Investigator at Quethera, Andrew has a strong background in research. Prior to their industry roles, Andrew also served as a Postdoctoral Research Fellow at the University of Cambridge. Andrew holds a PhD in Ocular Pharmaceutical Cell Biology from the University of East Anglia, where Andrew also completed their BSc in Biological Sciences.